Bristol Myers Squibb

1:45 PM - 2:00 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 104B
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb , visit us at BMS.com
Ticker:
BMY
Exchange:
NYSE
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
NY
Company HQ Country:
United States
Year Founded:
1858
Main Therapeutic Focus:
Multiline Global Biopharma
Lead Product in Development:
Multiple
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
Vice President of Corporate Development Assessments
Bristol Myers Squibb